The programme for Rudolf Buchheim 200: New Essays on the Doctrine of Drugs
|
||
| 12.00 | Registration desk open Tartu University Library | |
| 18.00 | Opening | |
| 18.10 | ►History of Chemistry in University of Tartu Prof. Enn Lust (University of Tartu) |
|
|
18.40 |
Plenary lecture ►Rudolf Buchheim - materia medica becomes modern pharmacology Prof. Lars Oreland (Uppsala University) |
|
| 19.40 | Welcome reception at the Old Anatomical Theatre | |
|
15 May, University of Tartu Library |
||
| 8.20 | Plenary lecture ►Pharmacogenomics – update and future directions Prof. Ingolf Cascorbi (Kiel University) President of IUPHAR |
|
| 9.00 | Coffee | |
| 9.30 | Parallel symposium 1: Psychopharmacology | Parallel symposium 2: Recent Advancements in Drug Design and Delivery |
| ►The legacy of Arvid Carlsson: the past, present and future of psychopharmacology Prof. Elias Eriksson (University of Gothenburg) |
►Nanocrystal based formulations in drug delivery Prof. Leena Peltonen (University of Helsinki) |
|
| ►Neuroscience-based drug interventions for Mental Health disorders: A serendipitous choice? Prof. Gregers Wegener (University of Aarhus) |
►Finding new RNA targeting drug molecules Prof. Mati Karelson (University of Tartu) |
|
| ►Protein kinase C - A challenging drug target for brain diseases Prof. Raimo Tuominen (University of Helsinki) |
►Peptide-based drug delivery systems: preclinical development and applications in biotechnology Dr. Kaido Kurrikoff (University of Tartu) |
|
| ►Ultrasonic vocalizations in a neurodevelopmental model of schizophrenia Prof. Piotr Popik (Maj Institute of Pharmacology of the Polish Academy of Sciences) |
►Preclinical and clinical development of vascular homing peptides for precision medicine Prof. Tambet Teesalu (University of Tartu) |
|
| TBA | ||
| 11.30 | Coffee | |
| 12.00 | Plenary lecture ►Oswald Schmiedeberg Lecture: Neuropeptide signaling: A possible target for drug development Prof. Tomas Hökfelt (Karolinska Institutet) |
|
| 12.45 | Lunch | |
| 13.45 | Parallel symposium 3: Oncology | Parallel symposium 4: Network for European Clinical Trials for Children |
| ►PGx of TKI resistance Prof. Ingolf Cascorbi (Kiel University) |
►From microsampling to miniature mass spectrometers - advances in bioanalysis with limited sample volume Dr. Karin Kipper (Epilepsy Society, Head of Therapeutic Drug Monitoring Unit, UK) |
|
| ►Current and future drugs in immunotherapy Prof. Pärt Peterson (University of Tartu) |
►The effects of augmented renal clearance on the pharmacokinetic profile of antibiotics Dr. Lenne-Triin Kõrgvee (Tartu University Hospital, University of Tartu) |
|
| ►Endocrine side effects of new oncological drugs Prof. Vallo Volke (University of Tartu) |
►Measurement of glomerular filtration rate using iohexol Dr. Hiie Soeorg (University of Tartu) |
|
| ►Latest developments in pharmacotherapy of cancer Dr Kersti Oselin (the North Estonia Medical Centre) |
►Vancomycin and DosOpt Dr Riste Kalamees (Tartu University Hospital, University of Tartu) |
|
| ►Pharmacokinetics of spironolactone in children under 2 years Dr Jana Lass (Tartu University Hospital, University of Tartu) |
||
| ►Pharmacokinetics and concentration related effects of dobutamine in neonates Dr Maarja Hallik (East Tallinn Central Hospital) |
||
| 15.00 | Parallel symposium 5: Emerging drugs in Endocrinology and Diabetes | |
| ►CV efffects of diabetes drugs Prof Troels Krarup Hansen (Aarhus University) |
||
| ►Twincretins- the future of diabetes and obesity management? TBC |
||
| 16.00 | ►Secrets of GLP-1 receptor agonists Dr. Ingrid Reppo, Prof Vallo Volke (University of Tartu) |
Parallel symposium 6: Protein drugs for CNS disorders |
| ►New drugs for osteoporosis Prof Ugis Gruntmanis (University of Texas) |
Details available in 3 weeks | |
| 17.00-19.00 | Walking tour on Toome Hill and the Town Hall Square | |
| 20.00-23.00 | Gala Dinner at the University of Tartu Museum | |
|
16 May, University of Tartu Library |
||
| 8.20 | Plenary lectures ►Pharmacovigilance: from reactive to proactive and predictive Prof. Lembit Rägo (Secretary-General CIOMS) |
|
| 8.50 | ►Can dysregulated myelination be linked to ADHD pathogenesis and does this generate new treatment targets? Prof. Klaus-Peter Lesch (University Hospital of Würzburg) |
|
| 9.30 | Coffee | |
| 10.00 | Parallel symposium: Addiction from Animal to Hospital | Parallel symposium: New drugs in Cardiology |
| ►Trace amine-associated receptor 1 (TAAR1): a promising target for the treatment of mental disorders Prof. E. Zvartau; I Sukanov (First Saint Petersburg State Pavlov Medical University) |
Details available in 3 weeks | |
| ►Epigenetics and Psychostimulant Addiction Prof. Anti Kalda (University of Tartu) |
||
| ►Extended release naltrexone for opioid use disorders: Advantages and problems Prof. Evgeny Krupitsky (First Saint Petersburg State Pavlov Medical University) |
||
| ►Personalized psychopharmacology through animal models Prof. Jaanus Harro (University of Tartu and North Estonia Medical Centre) |
||
| 12.30 | Closing remarks | |
| 14.00-16.30 | Excursion to the Estonian National Museum (bus transport provided) | |
| Delegate Services: Publicon OÜ, Väike-Turu 8, 51004 Tartu, Estonia Manager of Delegate Services: Ms Kristin Lillemäe T: +372 7404095 E: buchheim200@publicon.ee ; |
The conference has been supported by the City of Tartu
|
Official tourist information website
|
 |
 |
 |